Yüklüyor......
Progress: Targeted Therapy, Immunotherapy, and New Chemotherapy Strategies in Advanced Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer, accounting for approximately 15% of cases, and is defined by the lack of expression of hormone receptors (estrogen and progesterone receptors) and lack of amplification or overexpression of human epidermal...
Kaydedildi:
| Yayımlandı: | Cancer Manag Res |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7533235/ https://ncbi.nlm.nih.gov/pubmed/33061626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S272685 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|